6533b870fe1ef96bd12cf6f0
RESEARCH PRODUCT
Proteomics to elucidate the molecular physiology of Microbispora sp. ATCC-PTA-5024, the producer of NAI-107, a very promising lantibiotic
G. GalloE. PalazzottoT. FaddettaG. RenzoneP. MonciardiniS. ArenaA. GiardinaR. AlduinaR. PozziE. StegmannT. WeberA. RussoF. SangiorgiG. SpinelliM. SosioA. ScaloniA. M. Pugliasubject
Microbispora sp. ATCC-PTA-5024 lantibiotic NAI-107 ProteomicsSettore BIO/19 - Microbiologia Generaledescription
The filamentous actinobacterium Microbispora sp. ATCC-PTA-5024 produces the lantibiotic NAI-107 (Maffioli et al., 2014), which is effective against multidrug-resistant Gram-positive pathogens (Jabés et al., 2011). In actinomycetes, the biosynthesis of antibiotics is generally elicited as a physiological response controlled by a complex regulatory network involving global regulators, playing pleiotropic roles, and pathway-specific regulators, which activate the biosynthesis of biologically active molecules (Bibb, 2005)
year | journal | country | edition | language |
---|---|---|---|---|
2015-01-01 |